Quantitative screening of engineered implants in a long bone defect model in rabbits.

We have standardized a long bone defect model in rabbits to quantitatively compare the bone healing performance of engineered biological implants and have tested the bone healing efficiency of porous cylindrical scaffolds (ø-h, 6-20 mm [diameter 6 mm, height 20 mm] porosity, 70%) that were produced from hydroxyapatite (HA), titanium (Ti), and a novel biodegradable polymer-bioceramic composite (PH70alphaTCP). Scaffolds were perfused with or without 20 x 10(6) rabbit periosteal cells (RPCs) in a bioreactor and implanted in a standardized 2 cm defect in rabbit tibiae. X-rays revealed that new bone had formed at 3 weeks after creation of the defects. At sacrifice after 10 weeks, bone corticalization was observed in the majority of animals. Although PH70alphaTCP scaffolds did not inhibit callus formation, histomorphometric analysis revealed that there was no bone within the biomaterial, in contrast to HA and Ti scaffolds (bone volume ranging from 10% to 25%). We found that Ti and HA scaffold had good osteoconductive properties, but only HA scaffolds seeded with RPCs contributed to long bone mechanical functionality, with the maximum energy and angle being 308% and 155% greater than in control defects without scaffold.

[1]  D. Kaplan,et al.  Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. , 2005, Tissue engineering.

[2]  S. O’Driscoll,et al.  Localization of chondrocyte precursors in periosteum. , 2001, Osteoarthritis and cartilage.

[3]  Robert Langer,et al.  In vivo engineering of organs: the bone bioreactor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  N. Bresolin,et al.  Alternative Sources of Neurons and Glia from Somatic Stem Cells , 2002, Cell transplantation.

[5]  P. Chambon,et al.  A Microenvironment-Induced Myeloproliferative Syndrome Caused by Retinoic Acid Receptor γ Deficiency , 2007, Cell.

[6]  M. Hirano,et al.  Mineralization ability of cultured human osteoblast-like periosteal cells does not decline with aging. , 1991, Journal of gerontology.

[7]  O. Hermanson,et al.  Getting the right stuff: Controlling neural stem cell state and fate in vivo and in vitro with biomaterials , 2007, Cell Research.

[8]  S. Mullens,et al.  New Processing Techniques of Ceramic Foams , 2003 .

[9]  O. Oni,et al.  Localisation of bone‐forming cells during fracture healing by osteocalcin immunocytochemistry: An experimental study of the rabbit tibia , 1994, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  H. Lee,et al.  In vivo osteogenic differentiation of rat bone marrow stromal cells in thermosensitive MPEG-PCL diblock copolymer gels. , 2006, Tissue engineering.

[11]  K. Harii,et al.  Osteogenic potential of cultured periosteal cells in a distracted bone gap in rabbits. , 1998, Journal of Surgical Research.

[12]  F. Luyten,et al.  Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. , 2006, Tissue engineering.

[13]  F. Luyten,et al.  Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. , 2001, Arthritis and rheumatism.

[14]  T. Goto,et al.  Bone lengthening in rabbits by callus distraction. The role of periosteum and endosteum. , 1988, The Journal of bone and joint surgery. British volume.

[15]  T. Lim,et al.  Induction of Ectopic Bone Formation by Using Human Periosteal Cells in Combination with a Novel Scaffold Technology , 2002, Cell transplantation.

[16]  M. Tsunoda,et al.  Role of fracture hematoma and periosteum during fracture healing in rats: interaction of fracture hematoma and the periosteum in the initial step of the healing process , 2000, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[17]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[18]  Antonios G. Mikos,et al.  Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. , 2007, Biomaterials.

[19]  Jos Vander Sloten,et al.  Micro-CT-based screening of biomechanical and structural properties of bone tissue engineering scaffolds , 2006, Medical and Biological Engineering and Computing.

[20]  Dietmar W Hutmacher,et al.  Periosteal cells in bone tissue engineering. , 2003, Tissue engineering.

[21]  Ralph Müller,et al.  Effect of scaffold design on bone morphology in vitro. , 2006, Tissue engineering.

[22]  Adam J. Engler,et al.  Supplemental Data Matrix Elasticity Directs Stem Cell Lineage Specification , 2006 .

[23]  V. Goldberg,et al.  In vivo osteochondrogenic potential of cultured cells derived from the periosteum. , 1990, Clinical orthopaedics and related research.

[24]  H. Ohgushi,et al.  Spatial distribution of mineralized bone matrix produced by marrow mesenchymal stem cells in self-assembling peptide hydrogel scaffold. , 2008, Journal of biomedical materials research. Part A.